Brexpiprazole CAS 913611-97-9 Ịdị Ọcha>99.0% (HPLC) API Foto egosipụtara

Brexpiprazole CAS 913611-97-9 Ịdị ọcha> 99.0% (HPLC) Ụlọ ọrụ API

Nkọwa dị mkpirikpi:

Aha ọgwụ: Brexpiprazole

CAS: 913611-97-9

Dị ọcha:> 99.0% (HPLC)

Ọdịdị: White ma ọ bụ Gbanyụọ-White Crystalline Powder

API Ogo dị elu, mmepụta azụmahịa

E-Mail: alvin@ruifuchem.com

Zitere anyị email

Nkọwa ngwaahịa

Ngwaahịa ndị emetụtara

Mkpado ngwaahịa

Nkọwa:

Ruifu Chemical Supply Brexpiprazole Intermediates
Brexpiprazole CAS 913611-97-9
7-Hydroxyquinolinone CAS 70500-72-0
4-Bromobenzo [b] thiophene CAS 5118-13-8
1- (1-Benzothiophen-4-yl) piperazine Hydrochloride CAS 913614-18-3
7- (4-Chlorobutoxy) quinolin-2(1H) -otu CAS 913613-82-8
4-Chlorobenzo[b]thiophene CAS 66490-33-3

Njirimara kemịkalụ:

Aha Chemical	Brexpiprazole
Ụdị okwu	OPC-34712;7- (4- (4- (Benzo [b]thiophen-4-yl) piperazin-1-yl) butoxy) quinolin-2 (1H) -otu
Nọmba CAS	913611-97-9
Nọmba CAT	RF-PI1982
Ọnọdụ Ahịa	N'ọkwa, Mpụta Ihe ruru Tọn
Usoro ihe omimi	C25H27N3O2S
Ibu molekụla	433.57
Njupụta	1.245±0.060 g/cm3
Ụdị	Ruifu Chemical

Nkọwapụta:

Ihe	Nkọwapụta
Ọdịdị	Ntụ ntụ kristal na-acha ọcha ma ọ bụ gbanyụọ
njirimara	Site na IR
RT	N'okpuru chirality kwesịrị ịgbaso
Chloride	Ọ na-enye mmeghachi omume nke chloride
Mmiri	3.0% ~ 4.5%
Ebe Na-agbaze	198.0-202.0 ℃
Ihe fọdụrụ na mgbanye	<0.20%
Ọla dị arọ	≤10ppm
Ihe ndị emetụtara
Ọdịghị ọcha nke Onwe Onye	<0.50%
Mgbakọta adịghị ọcha	<1.00%
EE	> 99.0%
Ụzọ ịdị ọcha / nyocha	> 99.0% (HPLC, na akọrọ)
Nlele ọkọlọtọ	Standardkpụrụ ụlọ ọrụ
Ojiji	API

Ngwungwu & Nchekwa:

ngwugwu: Kalama, Aluminom foil bag, 25kg / Cardboard Drum, ma ọ bụ dị ka ndị ahịa chọrọ

Ọnọdụ Nchekwa:Na-echekwa n'ime akpa ndị a kpuchiri ekpuchi na ebe dị jụụ na nke kpọrọ nkụ;Chebe site na ìhè na mmiri mmiri

Uru:

Ajụjụ:

Ngwa:

Brexpiprazole (CAS: 913611-97-9) bụ onye nyocha ọgwụ bara uru na ọgwụgwọ na mgbochi nke nsogbu uche gụnyere nsogbu CNS.Brexpiprazole bụ ọgwụ antipsychotic ọhụrụ nke na-arụ ọrụ dị ka onye na-emegharị ihe omume serotonin® dopamine ma gosipụtala ịdị irè dị ka ọgwụgwọ mgbakwunye na ndị ọrịa nwere nnukwu nsogbu ịda mbà n'obi (MDD).Brexpiprazole na-egosiputa profaịlụ ọgwụ pụrụ iche, na-eme dị ka agonist akụkụ nke serotonin 5-HT1A na dopamine D2 ndị na-anabata ya na dị ka onye na-emegide 5-HT2A na noradrenaline α1B/2C, nwere njikọ njikọ subnanomolar yiri ya.Ọ bụ Otsuka na Lundbeck mepụtara Brexpiprazole, FDA kwadoro na 2015 maka ọgwụgwọ schizophrenia yana dịka ọgwụgwọ mgbakwunye maka ịda mbà n'obi.A na-ele Brexpiprazole anya dị ka onye nọchiri anya ọgwụ antipsychotic nke Otsuka aripiprazole (aha ahia Abilify) nke patent mebie n'August 2014.